Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-11

FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FERAHEME (ferumoxytol) submitted by AMAG Pharmaceuticals, Inc., indicating an updated labeling or indication exp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Feraheme (ferumoxytol)

Snippet

SUPPL AP for FERAHEME (FERUMOXYTOL)